ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

3 AC&R Study Summaries: Avoidable RA Hospitalizations, Psoriasis to Psoriatic Arthritis Transition, & Neighborhood Conditions in Childhood Lupus

Arthritis Care & Research  |  Issue: September 2025  |  September 8, 2025

Avoidable Hospitalizations in Patients with RA

By Dani G. Contreras, MSc, & Cheryl Barnabe, MD, MSc, FRCPC

Why was this study done? People with rheumatoid arthritis (RA) may be at a higher risk for hospitalizations due to the consequences of systemic inflammation. Health service availability may also factor into the risk for hospitalization. People who may not have access to high-quality primary care may require admission for ambulatory care sensitive conditions (ACSCs), many of which reflect comorbidities associated with RA. This study aimed to estimate the rates of these avoidable hospitalizations among those with RA, compared with the general population.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

What were the study methods? We conducted a retrospective cohort study using population-level administrative data in Alberta, Canada (population ~5 million people), from 2007–23. We compared hospitalization rates for ACSCs in persons meeting the case definition for RA (determined using International Classification of Diseases codes), compared with matched controls. The ACSCs included grand mal seizures, chronic lower respiratory diseases, asthma, diabetes, heart failure and pulmonary edema, hypertension and angina. We estimated incidence rate ratios for all seven ACSCs combined and for each individual ACSC, adjusting for age, sex and primary location of residence. We used a Cox proportional hazards model to identify predictors for these avoidable hospitalizations.

What were the key findings? Compared with the control population, people with RA had an 11% higher risk of avoidable hospitalizations at three years from the time they were diagnosed and a 14% higher risk at five years after diagnosis. They were specifically at a higher risk of being hospitalized for heart failure and pulmonary edema, compared with those without RA. We found that increasing age, prolonged exposure to glucocorticoids and having comorbid conditions, especially if the condition is considered an ACSC, are significant predictors for these avoidable hospitalizations.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

What were the main conclusions? People with RA are at a higher risk of avoidable hospitalizations three and five years from the date of diagnosis, compared with those without RA. They are at especially high risk of being hospitalized for heart failure and pulmonary edema, compared with the general population.

What are the implications for patients & clinicians? This study highlights the need for better quality of care for persons with RA, specifically when dealing with comorbidities. We propose improved ambulatory care access and quality for RA patients, inclusive of primary and subspecialty care, to prevent unnecessary hospitalizations and reduce the burden on the acute care system.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsPsoriatic ArthritisResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RBiomarkersC-reactive proteinCardiovascular diseasechildhood-onset SLEcomorbiditiesDisparitieshospitalizedPediatric RheumatologyPsA Resource CenterPsoriasisRA Resource CenterReading RheumSLE Resource Centersocioeconomic

Related Articles

    Childhood-onset Lupus Brings Distinct Challenges at Each Phase of Life

    January 1, 2014

    Differences in disease manifestations, severity, and management require special consideration from rheumatologists who treat children and adolescents with systemic lupus erythematosus

    The Heterogeneity of Psoriatic Arthritis

    November 21, 2023

    SAN DIEGO—Differences between psoriatic arthritis and rheumatoid arthritis highlight the need for the development of imaging modalities, laboratory tests and other biomarkers that are explored and validated specifically for PsA to advance the goal of personalized or precision medicine. In this article, expert David S. Pisetsky, MD, PhD, explores the top research in psoriatic arthritis presented at ACR Convergence 2023.

    Psoriatic Arthritis: Advances in Therapeutics, Imaging & More Presented at ACR Convergence 2022

    December 1, 2022

    PHILADELPHIA—Selecting my top 10 picks for abstracts in psoriatic arthritis (PsA) at the ACR Convergence 2022 meeting was not easy because there was a great deal to review and learn from the 139 abstracts submitted to the meeting. I focused first and foremost on advances in therapeutics that encompassed both new and approved therapeutics, novel…

    Top Research in Psoriatic Arthritis Presented at ACR Convergence 2024

    November 26, 2024

    Editor’s note: What research on psoriatic arthritis (PsA) presented at ACR Convergence 2024 has the greatest potential for a positive impact on clinical care, treatment options or serve as the basis for future research? That’s the question The Rheumatologist asked David S. Pisetsky, MD, PhD—our founding editor—to consider. Dr. Pisetsky, a professor of medicine and immunology…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences